Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Take part in our new study looking at flu vaccines

The Oxford Vaccine Group, part of the University of Oxford, would like to invite you and your child to take part in a study to investigate the immune response to a flu vaccine.

We are looking to enroll healthy Caucasian children aged 13 to 24 months, these children would receive two doses of a flu vaccine and three blood tests. Healthy Caucasian adults aged 18 to 65 years are also able to participate, they would receive one dose of a flu vaccine and four blood tests. We would use local anaesthetic cream on the skin to reduce any discomfort from the blood sampling.

You would have 24 hour telephone access to a paediatrician, should you have any concerns following vaccination. Taking part in this study is voluntary.

If you would like to any further information please visit:

Our website

You can also contact us by telephone on 01865 857420 or you can e-mail us at info@ovg.ox.ac.uk.

 

Similar stories

Oxford to work with Brazil to establish clinical research hub

The University of Oxford and Brazilian Ministry of Health have announced a joint initiative to set up a global health and clinical research unit in Brazil led by Professor Sue Ann Clemens CBE.

Promising discovery for treatment of neuromuscular diseases

Research led by Carlo Rinaldi and Catheryn Lim discovered that a naturally-occurring isoform of an androgen receptor can be used in therapy for spinal and bulbar muscular atrophy, and shows potential for other diseases.

Vaccine for TB receives a $1.5 million funding boost

The Oxford-run VALIDATE Network has received $1.5 million in funding for its tuberculosis vaccine work from the Bill & Melinda Gates Foundation.

University of Oxford researchers among recipients of Ireland and UK joint research awards for digital humanities in €6.5m boost for interdisciplinary research partnerships

Dr Samantha Vanderslott (Oxford Vaccine Group) and Dr Claas Kirchhelle (University College Dublin) have had their three-year project ‘Typhoid, Cockles, and Terrorism’ about the history of typhoid in Dublin successfully funded.

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.